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Abstract
A novel severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) causing
COVID-19 pandemic in humans, recently emerged and has exported in more than 200
countries as a result of rapid spread. In this study, we have made an attempt to investigate
the SARS-CoV-2 genome reported from 13 different countries, identification of mutations in
major coronavirus proteins of these different SARS-CoV-2 genomes and compared with
SARS-CoV. These thirteen complete genome sequences of SARS-CoV-2 showed high
identity (>99%) to each other, while they shared 82% identity with SARS-CoV. Here, we per-
formed a very systematic mutational analysis of SARS-CoV-2 genomes from different geo-
graphical locations, which enabled us to identify numerous unique features of this viral
genome. This includes several important country-specific unique mutations in the major pro-
teins of SARS-CoV-2 namely, replicase polyprotein, spike glycoprotein, envelope protein
and nucleocapsid protein. Indian strain showed mutation in spike glycoprotein at R408I and
in replicase polyprotein at I671T, P2144S and A2798V,. While the spike protein of Spain &
South Korea carried F797C and S221W mutation, respectively. Likewise, several important
country specific mutations were analyzed. The effect of mutations of these major proteins
were also investigated using various in silico approaches. Main protease (Mpro), the thera-
peutic target protein of SARS with maximum reported inhibitors, was thoroughly investi-
gated and the effect of mutation on the binding affinity and structural dynamics of Mpro was
studied. It was found that the R60C mutation in Mpro affects the protein dynamics, thereby,
affecting the binding of inhibitor within its active site. The implications of mutation on struc-
tural characteristics were determined. The information provided in this manuscript holds
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Introduction
In the last two decades, three coronaviruses viz. severe acute respiratory syndrome coronavirus
(SARS-CoV) [1], Middle-East respiratory syndrome coronavirus (MERS-CoV) [2] and SARS-
CoV-2 have crossed the species barrier to cause deadly pneumonia in humans. In 2002, SARS-
CoV emerged in the Guangdong province of China and spread to five continents, infecting
8,098 people with 774 deaths. In 2012, MERS-CoV emerged in the Arabian Peninsula, trans-
mitted to 27 countries, infecting a total of ~2,494 individuals and claiming 858 lives. The
current outbreak of coronavirus disease 19 (COVID-19) caused by SARS-CoV-2, was first
reported in December 2019 in Wuhan, Hubei province of China [3, 4] and spread across 200
countries, infecting over 2.5 million people and killed more than 1.5 lakh as of April, 23, 2020.
SARS-CoV-2 was declared a pandemic by the World Health Organization on March 12, 2020.
SARS-CoV-2 belongs to the family Coronaviridae of genus Betacoronavirus, having positive
sense strand RNA genome of 26–32 kb size. SARS-CoV-2 genome has six major open reading
frames (ORFs) viz. replication enzyme coding region (ORF 1a and 1b), E gene (envelope pro-
tein), M gene (membrane protein), S gene (spike protein), and N gene (nucleocapsid protein)
that are common to coronaviruses and a number of other accessory genes (ORF 3a, 6, 7a, 7b
and 8) (Fig 1) [3]. The structural proteins: envelope protein, nucleocapsid protein, spike pro-
tein and membrane protein are essential for producing the structurally complete viral particle
[5–8]. Entry of coronavirus into host cells is guided by spike glycoprotein. ORF 1a and 1b
encode replication enzyme consisting 16 non-structural proteins (nsp1-16) that are highly
conserved among the coronaviruses. Main protease (Mpro, also known as 3CLpro) is one of
the important nsp encoded by ORF 1a and 1b, play an essential role in the processing of poly-
proteins and control the replication of coronavirus [9, 10]. RNA-dependent RNA polymerase
(RdRp) also known as nsp12, another important replicase catalyze the replication of RNA
using viral genomic RNA template [11].
Reports showed that MERS-CoV originated from bats, but the reservoir host fueling spill-
over to humans is unequivocally dromedary camels [12, 13]. Both SARS-CoV and SARS-CoV-
2 are originated from bats, which serve as reservoir host for these two viruses [3, 14, 15]. Rac-
coon dogs and palm civets have been identified as intermediate hosts for zoonotic transmis-
sion of SARS-CoV between bats and humans [16–18], however, the intermediate host of
SARS-CoV-2 remains unknown.
Mutation rate is very high in RNA viruses, up to a million times higher than their host,
which enhance their virulence and evolvability (formation of new species) [19]. Coronavirus
replication is error prone as compared to other RNA viruses and the estimated mutation rate
is 4x10-4 nucleotide substitutions/site/year [20]. The rate of SARS-CoV-2 mediated disease
spread and the mortality varies from country to country. Of several reasons affecting the rate
of disease spread and mortality, mutations within the SARS-CoV-2 strains is also considered
one of the major factors.
This study was conducted to gather additional information on the SARS-CoV-2 sequences
from different geographical locations infected with COVID-19. The genome analysis of the
SARS-CoV-2 strains from 13 different countries showed a large number of mutations within
the major structural proteins. This is the first time we have comprehensively investigated these
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mutations and also discussed their potential roles in the pathogenicity, replication and entry
of virus particle. This study provides a deeper insight into the emergence of these mutations
within the major structural as well as nsp encoded by the SARS-CoV-2 genome from different
countries. Here, molecular dynamics and other in silico studies were also performed to investi-
gate the effect of mutations on the dynamics of Mpro. The findings of this study provide a clue
for the futuristic development of potential vaccine candidate or therapeutic design against
COVID19.
Material and methods
Sequence analysis and stability prediction
The genome sequence of ORF1ab for SARS with reference sequence ID: NC_004718.3 and pro-
tein sequence with GenBank ID: AAP41036.1, was retrieved from NCBI database. Similarly, the
genome sequence for SARS-CoV-2 with Reference Sequence ID: MT012098.1, MT019529.1,
MT039890.1, MT093571.1, MT192772.1, MT126808.1, MT192759.1, MN985325.1, MT007544.1,
LC529905.1, MT020781.2, MT072688.1 and MT066156.1 and protein sequence with GenBank
ID: QHS34545.1, QHU36823.1, QHZ00378.1, QIC53203.1, QIK50437.1, QIG55993.1,
QIK50416.1, QHO60603.1, QHR84448.1, BCB15089.1, QHU79171.2, QIB84672.1 QIA98553.1
for India, China, South-Korea, Sweden, Vietnam, Brazil, Taiwan, USA, Australia, Japan, Finland,
Nepal and Italy, respectively, were downloaded from NCBI. Multiple sequence alignment (MSA)
and visualization of SARS and SARS-CoV-2 sequences from 13 different countries was per-
formed using Molecular Evolutionary Genetics Analysis (MEGA) version 10.1.8. To delineate
and analyze the mutation across different countries, an in-house script written in Perl and
Python was used. MUPRO server was used to determine the effect of mutation on various SARS-
CoV-2 proteins [21].
Model building
The crystal structure of Mpro protein from SARS-CoV-2 in complex with Boceprevir (pdb id:
7BRP) was taken as a wildtype (WT). The structure of R60C was generated by inserting the
Point mutation and modelled using modeler 9v13 [22].
Molecular docking
Boceprevir was retrieved and redocked within the structure of Mpro using CCDC Gold. The
RMSD for the crystal and redocked conformation of Boceprevir were compared. Further,
Fig 1. Schematic representation of genome organization of SARS-CoV-2.
https://doi.org/10.1371/journal.pone.0238344.g001
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Boceprevir was subjected to dock within the active site of R60C mutant. The poses were visual-
ized on PMV viewer [23].
Molecular dynamics simulations of the protein and their complexes
The structure of Boceprevir in complex with Mpro (WT) and R60C mutant was subjected to
energy minimization using Gromacs-5 with the CHARMM27 all atom force field [24–26]. The
models were solvated with a SPC/E water model in a cubic periodic box with 1 nm distance
from the edge of the complex atoms. The solvated system was neutralized by seven chloride
ions. The system was, thereafter, minimized using steepest descent algorithm with conver-
gence criteria of tolerance value 1000 kJ mol−1 nm−2. The complete simulation of minimized
solvated proteins was performed under periodic boundary condition with time step of 2 fs.
Particle mesh Ewald was used for long range electrostatic interactions with an interpolation
order of 4 and a Fourier spacing of 0.16. The first phase simulation was conducted under an
NVT ensemble for 500 ps by keeping all bonds constrained using the LINCS algorithm for
temperature equilibration. The system was heated to 300 K using leap-frog integrator while
pressure coupling was set off. A V-rescale thermostat was used to maintain constant tempera-
ture for each system, followed by pressure equilibration at 300 K using Parrinello-Rahman
pressure coupling algorithm under an isothermal-isobaric ensemble for another 500 ps at 1.0
bar. Isothermal compressibility of the solvent was set to 4.5e-5 bar−1. Further, simulation of
50000 ps production run was carried out at 300 K and 1 atm pressure for trajectory analysis.
The final models obtained at the end of MD were validated and taken for structural analysis.
Results
Sequence analysis and mutation detection
The complete nucleotide sequences of 13 SARS-CoV-2 reported from 13 different countries
showed ~82% sequence identity with SARS-CoV. Also, all 13 sequences shared more than 99%
sequence identity to each other. Replicase polyprotein (ORF 1ab) of 13 isolates, which are
most conserved in all coronaviruses shared maximum identity (87%) with SARS-CoV
(NC_0047180), which is less than the threshold value (90%) for demarcation of betacorona-
virus species [27, 28]. Phylogenetic analysis revealed that all 13 SARS-CoV-2 identified from
different geographical locations clustered together in a single clad as compared to SARS-CoV
(Fig 2A and 2B).
Further, we checked the mutation in all major proteins of 13 SARS-CoV-2 sequences and
compared with SARS-CoV. ORF 1a and 1b showed 11 changes among all 13 SARS-CoV-2.
Indian SARS-CoV-2 sequence showed three changes at 671 (Isoleucine to Threonine), 2144
(Proline to Serine) and 2798 (Alanine to Valine) compared to all other 12 isolates. Here, we
also noted two amino acid mutations (in ORF1ab) in each SARS-CoV-2 sequences isolated
from China (2708: Asparagine to Serine; 2908: Phenylalanine to Isoleucine), South Korea (902:
Methionine to Isoleucine; 6891: Threonine to Methionine) and Sweden (818: Glycine to Ser-
ine; 4321: Phenylalanine to Leucine). Brazil and Vietnam isolate showed only one change at
3606 (Leucine to Phenylalanine) and 3323 (Arginine to Cystine), respectively (Table 1). 996
changes have been reported when ORF 1a and 1b amino acid sequences of all 13 SARS-CoV-2
was compared with SARS-CoV (S1 File).
The viral Mpro controls the replication of coronavirus and is a key protein responsible for
its life cycle [29–31]. Mpro is an attractive drug discovery target. The analysis of Mpro reveals
that there was only one point mutation (R60C) in the Vietnam strain of SARS-CoV-2 (Fig
3A). RdRp, which is another important target for antiviral drugs functions by catalyzing the
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viral RNA synthesis [32]. Only one mutation (A406V) was observed in the RdRp of Indian
SARS-CoV-2 isolate (Fig 3B).
Spike proteins are the key surface glycoproteins and are well reported for their prominent
role in interaction with host cell receptors [33, 34]. Here, we analyzed the mutations in the
spike protein of SARS-CoV-2 from different countries. It was found that this glycoprotein
carried five different amino acid mutations at various positions within the investigated
SARS-CoV-2 isolates. For instance, India, Finland, Australia, South Korea and Sweden
SARS-CoV-2 isolates showed one amino acid change at 408 (Arginine to Isoleucine), 49
(Histidine to Tyrosine), 247 (Serine to Arginine), 221 (Serine to Tryptophan) and 797 (Phe-
nylalanine to Cysteine), respectively (Table 2 and Fig 3C). The value of ΔΔG show that the
mutant R408I (0.49732107 kcal/mol) mutation was having stabilization effect on spike pro-
tein. It was found that the mutation on the receptor binding domain (RBD) of spike protein
increases the stability.
When these 13 SARS-CoV-2 isolates were compared to SARS-CoV sequence, 1338 changes
have been reported (S1 File). The analysis of ORF3a showed 3 mutations within different
SARS-CoV-2 strains: W128L (South Korea), L140V (Japan), G251V (Australia, South Korea,
Brazil, Italy, Sweden) (Table 3).
One amino acid change occurred in each envelope protein of South Korea SARS-CoV-2
isolate at 37 (Leucine to Histidine) and nucleocapsid protein of Japan SARS-CoV-2 isolate at
344 (Proline to Serine) when compared among 13 SARS-CoV-2 isolates (Tables 4 and 5, Fig
3D and 3E), while, 5 and 45 changes has been reported in envelop and nucleocapsid proteins,
respectively as compared to SARS-CoV. Deletion of Glycine and Serine occurred at position
70 and 8 in envelop and nucleocapsid proteins, respectively, in all 13 SARS-CoV-2 isolates
Fig 2. Phylogenetic dendogram showing the relationship of SARS-CoV-2 complete sequence (nucleotide) from
different geographical locations (13 no.) with SARS-CoV (A) and amino acid sequence of replicase polyprotein of
13 SARS-CoV-2 with SARS-CoV (B). The evolutionary history was inferred using the Neighbor-Joining method.
https://doi.org/10.1371/journal.pone.0238344.g002
Table 1. Amino acid variation in replicase polyprotein of SARS-CoV-2 strains of 13 different countries.
Amino acid India China South Korea Sweden Vietnam Brazil Taiwan USA Australia Japan Finland Nepal Italy
671 T I I I I I I I I I I I I
818 G G G S G G G G G G G G G
902 M M I M M M M M M M M M M
2144 S P P P P P P P P P P P P
2708 N S N N N N N N N N N N N
2908 F I F F F F F F F F F F F
3323 R R R R C R R R R R R R R
3606 L L L L L F L L L L L L X
4321 F F F L F F F F F F F F F
4798 V A A A A A A A A A A A A
6891 T T M T T T T T T T T T T
https://doi.org/10.1371/journal.pone.0238344.t001
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when compared to SARS-CoV. MEM glycoprotein did not show any amino acid change
among 13 SARS-CoV-2 isolates, while 24 changes occurred when compared to SARS-CoV (S1
File). All the other point mutations occurring within the structural proteins of SARS-CoV-2
isolates from different countries were found to decrease protein stability (Table 6).
Molecular Dynamics (MD) studies
In the present study, we performed the MD simulations for the Boceprevir bound complexes of
SARS-CoV-2 Mpro and its R60C mutant to study the effect of mutation on the protein dynamics.
Root-Mean-Square Deviation (RMSD)
The root mean square deviations of the backbone were calculated to analyze the trajectories of
Mpro from SARS-CoV-2 and its R60C mutant. In the complex form, a slight fluctuation in the
Fig 3. Alignment of SARS-CoV-2 major proteins (A) main protease, (B) RNA-dependent RNA polymerase, (C)
spike proteins, (D) envelope proteins and (E) nucleocapsid proteins from different countries.
https://doi.org/10.1371/journal.pone.0238344.g003
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backbone RMSD was also noticed (Fig 4A). It was found that the RMSD of mutant was com-
paratively more stable than its WT. This variation in the average RMSD values suggests that
this mutation was affecting the dynamic behavior of Mpro.
Radius of gyration and SASA
Fig 4B illustrates the Rg of Cα atoms plot of the complexed Mpro from SARS-CoV-2 and the
Vietnam mutant Mpro (R60C). The R60C mutant shows slightly lower value for Rg as com-
pared to its WT. This suggests that R60C mutation affects the stability of Mpro. Fig 4C shows
the change of SASA of native and R60C mutant with time. The greater value of SASA for R60C
mutant (in complexed form) was supported by Rg plot [35].
Root Mean Square Fluctuation (RMSF)
RMSF values of native as well as R60C mutant Mpro were calculated to determine the impact of
mutation on dynamic behavior of protein at residue level. RMSF plot clearly indicates the fluctu-
ation in residues and showed the existence of higher degree of flexibility in R60C mutant Mpro.
It was found that the maximum amino acid fluctuation was in the region 50–76 and 127–222
(Fig 4D). The binding studies also confirm that the residues falling within this region were very
much involved in accommodating the inhibitor within the active site of Mpro [29, 31].
Interaction energy and effect on hydrogen bond network
Throughout the MD trajectory, the interaction energy of ligand in complex with the surround-
ing protein residues of WT and mutant Mpro were calculated. The Lennard–Jones short-
Table 6. Mutation in SARS-CoV-2 proteins from different geographical locations and their predicted effect on
protein stability.
Protein Name Mutation Country Stability effect (MUPRO)
3C-like proteinase (3CLpro) R60C Vietnam DECREASE stability (ΔΔG
-1.0163868)
Envelope Protein L37H South Korea DECREASE stability (ΔΔG
-2.4215632)
ORF3a W128L South Korea DECREASE stability (ΔΔG
-0.39593766)
L140V Japan DECREASE stability (ΔΔG
-0.90740107)




Spike Protein H49Y Finland DECREASE stability (ΔΔG
-0.20900128)
S221W Brazil DECREASE stability (ΔΔG
-0.45085799)
S247R Australia DECREASE stability (ΔΔG
-1.3464875)
R408I India INCREASE stability (ΔΔG
0.49732107)
F797C Sweden DECREASE stability (ΔΔG
-1.501262)




A406V India DECREASE stability (ΔΔG
-0.76907034)
https://doi.org/10.1371/journal.pone.0238344.t006
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range (LJ-SR) and Coulombic short-range (Coul-SR) potential energies were calculated
throughout the course of 50 ns of MD simulation (Fig 4E). The average interaction energy for
50 ns are shown in Table 7. It was found that the binding of inhibitor within the active site of
Mpro (WT) was stronger as compared to the R60C mutant. The analysis of hydrogen bond
network revealed that the R60C mutation also cause disturbance in the interactions with inhib-
itor as well as other surrounding active site residues of Mpro. A large fluctuation was noticed
in the hydrogen bond network of Mpro and its R60C mutant (Fig 5A). It was found that R60C
mutation results in the changes in local environment that cascade further to the short helix
and loop of the catalytic active site of Mpro.
Discussion
Till date (April 23, 2020), 2.6 million cases of COVID-19 have been reported worldwide. In
this study, we analyzed 13 complete sequences of SARS-CoV-2 reported from 13 different
countries and compared with SARS-CoV. Phylogenetic analysis showed that SARS-CoV-2
sequences clustered together in a single clad irrespective of their geographic origin, whether
from the same continent or neighboring countries. Replicase polyprotein, which are most con-
served among coronaviruses, shared 87% amino acid sequence similarity to SARS-CoV, less
Fig 4. Molecular dynamics of complexed SARS-CoV-2 Mpro and the R60C mutant. Green color indicates the
SARS-CoV-2 Mpro while the cyan color indicates the R60C mutant Mpro. (A) Backbone RMSDs of Mpro and its
mutated form (B) Rg of Cα atoms (C) Change in Solvent accessible surface area (D) RMSF of the backbone atoms (E)
The Lennard–Jones short-range (LJ-SR) and Coulombic short-range (Coul-SR) potential energies.
https://doi.org/10.1371/journal.pone.0238344.g004
Table 7. The Lennard–Jones short-range (LJ-SR) and Coulombic short-range (Coul-SR) potential energies calcu-
lated throughout the course of 50 ns of MD simulation.
Complex Average (kJ/mol) Total drift (kJ/mol)
LJ-SR:Mpro(WT)- Boceprevir -158.90 18.54
LJ-SR:Mpro(R60C)- Boceprevir -134.43 -19.01
Coul-SR: Mpro(WT)- Boceprevir -65.37 17.45
Coul-SR: Mpro(R60C)- Boceprevir -59.56 6.49
https://doi.org/10.1371/journal.pone.0238344.t007
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than the threshold value (90%) for demarcation of betacoronavirus species [27]. They belong
to new virus species Severe acute respiratory syndrome-related coronavirus of genus Betacoro-
navirus [28].
Among all known RNA viruses, coronaviruses consist of the largest genome (26.4 to 31.7
kb) [36, 37]. The large genome size provides more plasticity in accommodating and modifying
genes [36–38]. Mutation frequency is very high in RNA viruses, which enhances virulence and
responsible for the formation of new species [19]. The high frequency of mutation within the
viral genome at different geographical locations may be one of the reasons that SARS-CoV-2 is
responsible for change in mortality rate and symptom of the disease [39]. The comparison of
amino acid sequences of replicase polyprotein of 13 SARS-CoV-2 showed mutations in India,
China, South Korea, Sweden, Vietnam and Brazil strains at different amino acid locations. Ear-
lier report showed the similar result i.e. a single mutation in replicase polyprotein at 3606 (L to
F) [40]. We could identify few more single amino acid mutations at different positions in
above mentioned SARS-CoV-2 strains (Table 1). The replicase polyprotein codes for nsp2 and
nsp3 and it has been suggested in previous research that the mutation in nsp2 and nsp3 play a
key role in infectious capability and are responsible for the differentiation mechanism of
SARS-CoV-2 [39].
The RBD of spike protein is the region which specifically interact with ACE2 leading to
viral entry into the host cell [41–43]. The Indian isolate of SARS-CoV-2 showed mutation
within this region where at 408 position, Arginine is replaced by Isoleucine. For several years,
the prediction of protein stability via theoretical or experimental approaches has been a pro-
found area of research [44]. Earlier findings suggest that a single point mutation at RBD is
responsible for disrupting the antigenic structure, thereby, affecting the binding of RBD to
ACE2 [45, 46]. The mutation within this region of spike protein may affect the binding of
RBD to its receptor, thus, affecting the viral entry within the host cells. Further, in silico studies
revealed that this point mutation within the RBD of spike glycoprotein was having stabilization
effect on spike protein and found to increase the protein stability (ΔΔG 0.49732107 kcal/mol).
Single amino acid mutation was observed in both Mpro (R60C) of SARS-CoV-2 Vietnam
isolate and RdRp (A408V) of SARS-CoV-2 India isolate. The in silico findings revealed that the
mutations in both strains decrease the stability of protein. The MD simulation studies on
Fig 5. (A) The hydrogen bond network of the Mpro (WT) and R60C mutant. (B) The Structure of WT and R60C
mutant Mpro.
https://doi.org/10.1371/journal.pone.0238344.g005
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Mpro further confirmed that the point mutation on Mpro affects the stability of proteins as
well as the binding of inhibitor. Our in silico study found that the catalytic active site of Mpro
is surrounded by amino acid residues of a loop (142–145, 175–200), short helix (40–43, 46–
50), and beta sheet regions (25–27, 164–167). The R60C mutant lies at helix adjacent to the
short helix (H2) that forms the catalytic channel (Fig 5). Substitution of an amino acid with
charged side chain to uncharged cysteine residue leads to loss of conserved ionic bond interac-
tion and the effect cascades to other conserved ionic interactions. Loss of conserved ionic
interaction was observed between amide nitrogen of arginine and carboxylic oxygen atom of
aspartic acid at position 48 of the catalytic channel.
It was found that the short helix H2, that form the catalytic channel, have attained a more
flexible loop like conformation in the mutant protein. Conserved hydrogen bonded interac-
tions that stabilizes the catalytic channel L1 loop between Tyr54 OH� � �Asp187 Oδ1, Tyr54
OH� � �Asp187 O and Leu50 O� � �Arg188 NE were lost in the mutant enzyme, thereby, increas-
ing the flexibility of structure forming the binding pocket (Fig 5B). Therefore, the local change
of an ordered secondary structure to a more disordered loop like structure have increased the
overall flexibility of the secondary structure elements forming the catalytic pocket, thereby,
effecting the binding of ligand to residue in the catalytic channel. This is quite evident from
the reduced LJ-SD and coulombic-SR interaction energies between the enzyme and ligand in
wild and mutant complexes (Fig 4E and Table 7). The role of important active site residues,
discussed in this study, has been reported before [47, 48]. The RMSF plot also reveals the key
role of these residues in accommodating the inhibitor within the active site of Mpro.
Envelop protein plays an important role in the assembly of viral genome and the formation
of ion channels (IC), responsible for virus-host interaction, which is mainly associated with
pathogenesis [5, 49]. We detected one amino acid mutation L37H in transmembrane domain
(TMD) of envelop protein of SARS-CoV-2 South Korea isolate. The TMD is hydrophobic in
nature consisting mainly hydrophobic amino acids, while the mutation in TMD at 37 position
changes hydrophobic to hydrophilic amino acid which changes the integrity of TMD. Earlier
report showed that mutations within the TMD domain of envelop protein completely dis-
rupted IC activity [50]. This might be one of the reasons for slow spreading/low pathogenicity
of SARS-CoV-2 in South Korea.
Nucleocapsid protein of coronavirus is necessary for RNA replication, transcription and
genome packaging [51, 52]. A mutation P344S in nucleocapsid protein has been detected in
SARS-CoV-2 Japan strain. The P344S mutation on nucleocapsid was found to decrease the
protein stability (ΔΔG -1.2252261). This mutation is located in carboxy-terminal RNA-binding
domain (CTD) of nucleocapsid protein. Earlier studies showed that CTD is responsible for
oligomerization [53].
It was also revealed that among all the genomes studied in this study, the Indian SARS-
CoV-2 isolates were carrying maximum mutation. The Indian isolates were carrying the R408I
on the spike protein while A406V on the RdRp and several mutations on the replicase polypro-
tein of SARS-CoV-2. It is expected that these large number of mutations among the SARS-
CoV-2 may affect the vaccine/inhibitor development against these isolates.
Conclusion
To conclude, SARS-CoV-2 complete sequences from 13 countries were analyzed and com-
pared with SARS-CoV. We identified country specific mutations in major proteins (replicase
polyprotein, spike protein, envelop protein and nucleocapsid protein). Further, molecular
dynamics and other in silico studies revealed that mutations decrease the stability of protein
and also hinders the binding of inhibitor. Mutation R408I in spike protein of Indian strain has
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significant influence on RBD domain of spike protein and this point mutation has a stabiliza-
tion effect on the spike protein. The findings of the present study could help for the design of
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